MassBio Winter 2016 Newsletter:
A Patient’s Desire to Help

Laabs’ foundation and Aura Biosciences advance efforts to develop new and better therapies to treat rare cancer patients. “By enabling physicians to treat cancer more selectively, effectively and safely than they can do today, we aim to eliminate the need for risky procedures that carry significant morbidity and often do little to improve a patient’s overall survival,” said Aura’s Founder and CEO Elisabet de los Pinos.

Written by:

Comment on this blog post by clicking the Post Comment button below, clicking the icon, and entering your name and email address. Any comments submitted without both a name and email address will not be approved to post publicly. For more information, read Aura’s blog guidelines here.